Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TNF-α controls Lipocalin-2 expression in PC-3 prostate cancer cells
Sarah K. Schröder, Anastasia Asimakopoulou, Stefan Tillmann, et al.
Cytokine (2020) Vol. 135, pp. 155214-155214
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Inflammatory Cytokines in Cancer: Comprehensive Understanding and Clinical Progress in Gene Therapy
Tianxia Lan, Li Chen, Xiawei Wei
Cells (2021) Vol. 10, Iss. 1, pp. 100-100
Open Access | Times Cited: 169
Non-coding RNA-based regulation of inflammation
Milad Ashrafizadeh, Ali Zarrabi, Ebrahim Mostafavi, et al.
Seminars in Immunology (2022) Vol. 59, pp. 101606-101606
Closed Access | Times Cited: 70
Targeting inflammation as cancer therapy
Manni Wang, Siyuan Chen, Xuemei He, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 30
Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
María F. Mercogliano, Sofía Bruni, Florencia Mauro, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 564-564
Open Access | Times Cited: 79
Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways
Amir R. Afshari, Mehdi Sanati, Hamid Mollazadeh, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 860-872
Closed Access | Times Cited: 55
The role of proinflammatory cytokines and CXC chemokines (CXCL1–CXCL16) in the progression of prostate cancer: insights on their therapeutic management
Amin Ullah, Jiao Wang, Bairong Shen
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 10
Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma
Anqi Li, Kun Zhang, Jiejun Zhou, et al.
International Journal of Biological Macromolecules (2024) Vol. 272, pp. 132797-132797
Open Access | Times Cited: 7
Dysfunctional adipocytes promote tumor progression through YAP/TAZ-dependent cancer-associated adipocyte transformation
Yaechan Song, Heeju Na, Seung Eon Lee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
DNA Damage-driven Inflammatory Cytokines: Reprogramming of Tumor Immune Microenvironment and Application of Oncotherapy
Mengjie Wang, Xia Yu, Qinglei Gao
Current Medical Science (2024) Vol. 44, Iss. 2, pp. 261-272
Closed Access | Times Cited: 4
MiRNAs and tempol therapeutic potential in prostate cancer: a preclinical approach
Isabela Maria Urra Rossetto, Letícia Ferreira Alves, Leonardo Augusto Marson, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 1
Closed Access
DOX-PLGA Nanoparticles Effectively Suppressed the Expression of Pro-Inflammatory Cytokines TNF-a, IL-6, iNOS, and IL-1β in MCF-7 Breast Cancer Cell Line
Rawan Hassan Al-Saeedi, Mohammad Khalaj‐Kondori, Mohammad Ali Hosseinpour Feizi, et al.
Reports of Biochemistry and Molecular Biology (2024) Vol. 12, Iss. 4, pp. 530-539
Open Access | Times Cited: 3
In Vitro Compression Model for Orthodontic Tooth Movement Modulates Human Periodontal Ligament Fibroblast Proliferation, Apoptosis and Cell Cycle
Julia Brockhaus, Rogerio B. Craveiro, Irma Azraq, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 932-932
Open Access | Times Cited: 23
Genetic Characterization of Rat Hepatic Stellate Cell Line HSC-T6 for In Vitro Cell Line Authentication
Indrajit Nanda, Claus Steinlein, Thomas Haaf, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1783-1783
Open Access | Times Cited: 15
Lipocalin-2 (LCN2) Deficiency Leads to Cellular Changes in Highly Metastatic Human Prostate Cancer Cell Line PC-3
Sarah K. Schröder, Manuela Pinoé-Schmidt, Ralf Weiskirchen
Cells (2022) Vol. 11, Iss. 2, pp. 260-260
Open Access | Times Cited: 14
Peripheral-central network analysis of cancer cachexia status accompanied by the polarization of hypothalamic microglia with low expression of inhibitory immune checkpoint receptors
Yukari Suda, Keiko Nakamura, Fukiko Matsuyama, et al.
Molecular Brain (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Thromboinflammatory Processes at the Nexus of Metabolic Dysfunction and Prostate Cancer: The Emerging Role of Periprostatic Adipose Tissue
Ibrahim AlZaim, Aya Al-Saidi, Safaa H. Hammoud, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1679-1679
Open Access | Times Cited: 12
Expression Analysis of Lipocalin 2 (LCN2) in Reproductive and Non-Reproductive Tissues of Esr1-Deficient Mice
Jan C. Kessel, Ralf Weiskirchen, Sarah K. Schröder
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9280-9280
Open Access | Times Cited: 6
Genetic Characterization of Rat Hepatic Stellate Cell Line PAV-1
Kiara Gäberlein, Sarah K. Schröder, Indrajit Nanda, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1603-1603
Open Access | Times Cited: 5
Rat Hepatic Stellate Cell Line CFSC-2G: Genetic Markers and Short Tandem Repeat Profile Useful for Cell Line Authentication
Indrajit Nanda, Sarah K. Schröder, Claus Steinlein, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2900-2900
Open Access | Times Cited: 8
Deep phenotyping of the prostate tumor microenvironment reveals molecular stratifiers of relapse and links inflammatory chemokine expression to aberrant metabolism
Sebastian Krossa, Maria Andersen, Elise Midtbust, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Mode of action exploration for prostate epithelial cell injury caused by bisphenol A
Baofang Liang, Jinyao Chen, Liang Wang, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 286, pp. 117228-117228
Open Access | Times Cited: 1
The Unfolded Protein Response Is a Major Driver of LCN2 Expression in BCR–ABL- and JAK2V617F-Positive MPN
Stefan Tillmann, Kathrin Olschok, Sarah K. Schröder, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4210-4210
Open Access | Times Cited: 9
Lipocalin-2 regulates the expression of interferon-stimulated genes and the susceptibility of prostate cancer cells to oncolytic virus infection
Lilach Barer, Sarah K. Schröder, Ralf Weiskirchen, et al.
European Journal of Cell Biology (2023) Vol. 102, Iss. 2, pp. 151328-151328
Open Access | Times Cited: 3
Novel 3,6-Disubstituted Pyridazine Derivatives Targeting JNK1 Pathway: Scaffold Hopping and Hybridization-Based Design, Synthesis, Molecular Modeling, and In Vitro and In Vivo Anticancer Evaluation
Mai M. Shaalan, Essam Eldin A. Osman, Yasmeen M. Attia, et al.
ACS Omega (2024) Vol. 9, Iss. 35, pp. 37310-37329
Open Access
Digital Spatial Profiling identifies phospho-JNK as a biomarker for early risk stratification of aggressive prostate cancer
Samaneh Eickelschulte, Adam Kaczorowski, Florian Janke, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top